About this blog

After seeing news articles say there was NO EVIDENCE that essential oils work for Ebola and hearing that the FDA has not approved any oils for any sort of disease, I decided to see what was out there and expose the essential oil industry. Instead, I found a mountain of peer reviewed studies for all kinds of serious diseases saying how well they work, even on Ebola! So, I decided to set up this blog to post a few studies a week to expose the real frauds and show the world what NO EVIDENCE looks like.
If you find value in my service, please donate to the blog since there is a cost to search and post these articles. I have waded through hundreds, if not thousands of difficult peer-reviewed articles to bring you those related to essential oils and ailments. I hope you find what you are looking for. I wish you great health, wealth and happiness!

(TIP: When looking for an article look in the Archive for titles but also use the Search Box because some articles may delay with say cancer in the title but also mention another disease so they may have tags that allow you to find them in the Search Box.)

Asthma and Allergies and Lavender


"Lvn (lavender essential oil) inhibits allergic inflammation and mucous cell hyperplasia with suppression of T-helper-2 cell cytokines and Muc5b expression in a murine model of asthma. Consequently, Lvn may be useful as an alternative medicine for bronchial asthma."

Lavender essential oil inhalation suppresses allergic airway inflammation and mucous cell hyperplasia in a murine model of asthma.

Ueno-Iio T1, Shibakura M2, Yokota K1, Aoe M1, Hyoda T1, Shinohata R1, Kanehiro A3, Tanimoto M3, Kataoka M1.

Abstract

AIMS: 

Lavender essential oil (Lvn) has been reported to have anti-inflammatory effects. Bronchial asthma is characterized by bronchial allergic inflammation with airway remodeling. Therefore, we evaluated the anti-inflammatory effect of Lvn on experimentally induced bronchial asthma in a murine model.

MAIN METHODS: 

BALB/c mice were sensitized by an intraperitoneal injection of ovalbumin (OVA) at days 0 and 14, and subsequently challenged with nebulized OVA on days 28-30 (Control-Asthma group). Mice in the treatment group inhaled Lvn on days 14-31 (Lvn-Asthma group). The allergic inflammatory response was determined on days 32 and 33.

KEY FINDINGS: 

An increase in airway resistance was inhibited in the Lvn-Asthma group than in the Control-Asthma group. The Lvn-Asthma group showed lower total cell numbers and eosinophils in bronchoalveolar lavage (BAL) fluids and peribronchial and perivascular tissues when compared with the Control-Asthma group. The Lvn-Asthma group also had less mucin hyperplasia than the Control-Asthma group. Furthermore, the Lvn-Asthma group showed lower interleukin (IL)-5 and IL-13 cytokine levels in BAL fluids, as well as reduced IL-4 and IL-5 mRNA expression in lung tissue, compared with the Control-Asthma group and determined by FlowCytomix and reverse transcriptase-polymerase chain reaction (RT-PCR), respectively. In addition, Lvn inhalation reduced Muc5b mRNA expression in the lungs without significantly changing the expression of Muc5ac mRNA.

SIGNIFICANCE: 

Lvn inhibits allergic inflammation and mucous cell hyperplasia with suppression of T-helper-2 cell cytokines and Muc5b expression in a murine model of asthma. Consequently, Lvn may be useful as an alternative medicine for bronchial asthma.
Copyright © 2014 Elsevier Inc. All rights reserved.

KEYWORDS: 

Alternative medicine; Asthma; Cytokines; Lavender; Mucin
PMID:
 
24909715
 
[PubMed - indexed for MEDLINE] 

Link to full article.

You are reading The Essential Oil Skeptic.
Subscribe by email for free for a limited time to see more scientific studies on essential oils
http://essentialoilskeptic.com
share: pinterest
Labels: , , , , , ,
 
site design by designer blogs